EP2364691
VEGF, mótlyfssamsetningar sem eru hentugar til gjafar í glerhlaup
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
14.6.2007EP published:
24.4.2013EP application number:
11157965.2
EP translation filed:
24.6.2013Grant published:
15.7.2013EPO information:
European Patent Register
Max expiry date:
13.6.2027Expiry date:
13.6.2026Next due date:
30.6.2026
Title:
VEGF antagonist formulations suitable for intravitreal administration
Timeline
Owner
Name:
REGENERON PHARMACEUTICALS, INC.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
Furfine, EricAddress:
Concord, MA, US
Name:
Dix, DanielAddress:
Lagrangeville, NY, US
Name:
Graham, Kenneth, S.Address:
Pleasant Valley, NY, US
Name:
Frye, KellyAddress:
Pomona, NY, US
Priority
Number:
814484 PDate:
16.6.2006Country:
US
Classification
Categories:
A61K 9/00, A61K 9/19, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 24.5.2013
Expires: 13.6.2014
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 20.5.2014
Expires: 13.6.2015
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 21.5.2015
Expires: 13.6.2016
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 10
Paid: 24.5.2016
Expires: 13.6.2017
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 11
Paid: 22.5.2017
Expires: 13.6.2018
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 12
Paid: 22.5.2018
Expires: 13.6.2019
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 13
Paid: 21.5.2019
Expires: 13.6.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 14
Paid: 19.5.2020
Expires: 13.6.2021
Payer: Patice ehf.
Number: 15
Paid: 19.5.2021
Expires: 13.6.2022
Payer: Patice ehf.
Number: 16
Paid: 18.5.2022
Expires: 13.6.2023
Payer: Patice ehf.
Number: 17
Paid: 24.5.2023
Expires: 13.6.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 21.5.2024
Expires: 13.6.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 10.6.2025
Expires: 13.6.2026
Payer: Árnason Faktor ehf.